medroxyprogesterone acetate has been researched along with Sensitivity and Specificity in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 13 (72.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caritis, S; Mada, SR; Mattison, D; Sharma, S; Torch, M; Venkataramanan, R; Zhang, S | 1 |
| Bell, B; Bourne, N; Johnston, R; Motamedi, M; Shilagard, T; Stanberry, L; Stegall, RL; Vargas, G; Vincent, K | 1 |
| Anderson, G; Aragaki, AK; Cauley, JA; Chlebowski, RT; Cochrane, BB; Crandall, CJ; Hendrix, SL; Kuller, LH; McTiernan, A | 1 |
| Charuruks, N; Chotnopparatpattara, P; Taneepanichskul, S; Treratanachat, S | 1 |
| Bozdoğan, O; Noyan, V; Sağsöz, N; Yücel, A | 1 |
| Bassford, T; Cauley, JA; Chen, Z; Green, SB; Jackson, RD; LaCroix, AZ; Leboff, M; Margolis, KL; Stefanick, ML | 1 |
| Barchi, D; Fiorucci, F; Gennuso, E; Giannetti, L; Neri, B; Pallagrosi, M; Sanna, P | 1 |
| Arai, T; Hamano, M; Jobo, T; Kamata, Y; Kawaguchi, M; Kuramoto, H; Nishimura, Y; Obokata, A; Watanabe, J | 1 |
| Chu, XG; Huo, TM; Liu, LQ; Peng, CF; Xu, CL | 1 |
| Kender, T; Lõhmus, M | 1 |
| Hu, CQ; Jin, SH; Liu, F; Shi, YQ; Yao, J; Yuan, J; Zhang, QM | 1 |
| Clinton, O; Earl, H; Moore, A; Murray, A; Price, M | 1 |
| Ces, J; Codesido, J; González, M; Macía, M; Novo, A; Quintana, S | 1 |
| Hunter, DJ; Maggwa, BN; Mati, JK; Mbugua, S | 1 |
| Baracat, EC; Bortoletto, CC; Gonçalves, WJ; Lima, GR; Stávale, JN | 1 |
| Bush, TL; Espeland, MA; Greendale, GA; Johnson, SR; Judd, HL; Legault, C; Trabal, J; Wasilauskas, CH | 1 |
| Rivera, R; Schwingl, P; Stang, A | 1 |
| McLachlan, RI; Morton, S; Pettersson, K; Pruysers, E; Robertson, DM; Stephenson, T | 1 |
5 trial(s) available for medroxyprogesterone acetate and Sensitivity and Specificity
| Article | Year |
|---|---|
New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.
Topics: Aged; Breast; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Pain; Postmenopause; Proportional Hazards Models; Sensitivity and Specificity | 2009 |
The effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1 expression in postmenopausal vaginal epithelium.
Topics: Adult; Apoptosis; Biomarkers; Biopsy, Needle; Cyclin D1; Epithelium; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Probability; Prognosis; Reference Values; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Treatment Outcome; Vagina | 2005 |
Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative.
Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Body Composition; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Muscle, Skeletal; Postmenopause; Sensitivity and Specificity | 2005 |
Assessment of five serum marker assays in patients with advanced breast cancer treated with medroxyprogesterone acetate.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Keratins; Medroxyprogesterone Acetate; Middle Aged; Mucin-1; Neoplasm Proteins; Prospective Studies; Sensitivity and Specificity | 1995 |
Agreement in assessing endometrial pathology: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Topics: Biopsy; Cell Transformation, Neoplastic; Double-Blind Method; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Observer Variation; Progesterone Congeners; Sensitivity and Specificity | 1998 |
13 other study(ies) available for medroxyprogesterone acetate and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS).
Topics: 17 alpha-Hydroxyprogesterone Caproate; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Methanol; Pregnancy; Progesterone; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Water | 2008 |
Use of high-resolution confocal imaging of the vaginal epithelial microstructure to detect microbicide toxicity.
Topics: Animals; Anti-Infective Agents; Cell Division; Epithelial Cells; Female; Medroxyprogesterone Acetate; Mice; Microscopy, Confocal; Mucous Membrane; Nonoxynol; Sensitivity and Specificity; Vagina | 2009 |
Relationship between progesterone receptor level in endometrium and bleeding pattern in depot medroxyprogesterone acetate users.
Topics: Adult; Amenorrhea; Biomarkers; Case-Control Studies; Cohort Studies; Contraceptive Agents, Female; Endometrium; Female; Humans; Incidence; Medroxyprogesterone Acetate; Probability; Progesterone; Reference Values; Risk Assessment; Sensitivity and Specificity; Uterine Hemorrhage | 2003 |
High-performance liquid chromatography-tandem mass spectrometry validation of medroxyprogesterone acetate in products of pork origin and serum.
Topics: Anabolic Agents; Animals; Chromatography, High Pressure Liquid; Food Contamination; Mass Spectrometry; Meat; Medroxyprogesterone Acetate; Reproducibility of Results; Sensitivity and Specificity; Swine | 2005 |
Medroxyprogesterone acetate stimulates cdk inhibitors, p21 and p27, in endometrial carcinoma cells transfected with progesterone receptor-B cDNA.
Topics: Blotting, Western; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; DNA, Complementary; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Receptors, Progesterone; Sampling Studies; Sensitivity and Specificity; Transfection; Tumor Cells, Cultured | 2006 |
Determination of medroxyprogesterone acetate residues by CE immunoassay with chemiluminescence detection.
Topics: Animals; Electrophoresis, Capillary; Immunoassay; Lod Score; Luminescent Measurements; Medroxyprogesterone Acetate; Sensitivity and Specificity | 2007 |
Determination of gestagens in kidney fat by liquid chromatography tandem mass spectrometry.
Topics: Calibration; Chemistry, Organic; Chlormadinone Acetate; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Kidney; Mass Spectrometry; Medroxyprogesterone Acetate; Megestrol Acetate; Melengestrol Acetate; Progestins; Reproducibility of Results; Sensitivity and Specificity; Solvents | 2007 |
Establishment of an HPLC identification system for detection of counterfeit steroidal drugs.
Topics: Chromatography, High Pressure Liquid; Diethylstilbestrol; Estriol; Ethinyl Estradiol; Medroxyprogesterone Acetate; Methyltestosterone; Norgestrel; Progesterone; Quinestrol; Sensitivity and Specificity; Steroids; Testosterone Propionate | 2008 |
Progesterone challenge test for the assessment of endometrial pathology in asymptomatic menopausal women.
Topics: Biopsy; Endometrial Neoplasms; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity | 1993 |
Validity of contraceptive histories in a rural community in Kenya.
Topics: Adult; Contraception; Contraceptives, Oral; Educational Status; Evaluation Studies as Topic; Female; Humans; Interviews as Topic; Intrauterine Devices; Kenya; Life Change Events; Medical History Taking; Medical Records; Medroxyprogesterone Acetate; Memory; Middle Aged; Parity; Reproducibility of Results; Rural Population; Sensitivity and Specificity | 1993 |
Transvaginal ultrasonography and the progestogen challenge test in postmenopausal endometrial evaluation.
Topics: Atrophy; Biopsy; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Sensitivity and Specificity; Ultrasonography | 1997 |
New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes.
Topics: Community Health Services; Contraceptives, Oral, Combined; Delayed-Action Preparations; Eligibility Determination; Family Planning Services; Female; Humans; Medroxyprogesterone Acetate; Practice Guidelines as Topic; Program Evaluation; Sensitivity and Specificity; World Health Organization | 2000 |
Sensitive LH and FSH assays for monitoring low serum levels in men undergoing steroidal contraception.
Topics: Contraceptive Agents, Male; Dose-Response Relationship, Drug; Fluoroimmunoassay; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Reagent Kits, Diagnostic; Sensitivity and Specificity; Sperm Count; Testosterone | 2001 |